Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DNUJ | ISIN: US45784J3032 | Ticker-Symbol: PST0
Frankfurt
06.02.26 | 08:11
4,460 Euro
-9,72 % -0,480
1-Jahres-Chart
INNOVATE CORP Chart 1 Jahr
5-Tage-Chart
INNOVATE CORP 5-Tage-Chart
RealtimeGeldBriefZeit
4,4204,72006.02.

Aktuelle News zur INNOVATE CORP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoINNOVATE Corp.: INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend1
MoINNOVATE Corp. - 8-K, Current Report2
16.12.25INNOVATE Corp.: MediBeacon Next Generation TGFR System Receives FDA Approval1
16.12.25INNOVATE Corp. - 8-K, Current Report-
13.11.25Innovate Corp. outlines $1.6B adjusted backlog momentum as asset sales process advances1
12.11.25INNOVATE Corp. Announces Third Quarter 2025 Results121- Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China --...
► Artikel lesen
INNOVATE CORP Aktie jetzt für 0€ handeln
12.11.25INNOVATE Corp. - 10-Q, Quarterly Report-
22.10.25INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th1
21.10.25INNOVATE Corp.: MediBeacon receives regulatory approval to sell the Transdermal GFR System in China390MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for...
► Artikel lesen
16.10.25INNOVATE Corp. - 8-K, Current Report2
16.10.25INNOVATE Corp.: INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend2
09.09.25INNOVATE Corp. - 8-K, Current Report1
09.09.25INNOVATE Corp.: INNOVATE's Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial Skin Continuing to Redefine Aesthetic Innovation1
05.08.25INNOVATE Corp. Announces Second Quarter 2025 Results174- Infrastructure: Improved financial flexibility with recent refinancing transactions -- Life Sciences: R2 continuing to see significant year over year growth in system unit sales -- Spectrum: Launched...
► Artikel lesen
04.08.25INNOVATE Corp.: INNOVATE Closes Indebtedness Refinancing Transactions217NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) ("INNOVATE" or the "Company") today announced that it has closed a series of previously announced indebtedness refinancing transactions...
► Artikel lesen
17.07.25INNOVATE Corp.: INNOVATE Launches Indebtedness Refinancing Transactions218$48.7 million privately negotiated convertible notes exchanges.$330 million exchange offer of senior secured notes and solicitation of consentsAgreement in principle to extend revolving credit agreementAgreement...
► Artikel lesen
06.05.25INNOVATE Corp. Announces First Quarter 2025 Results109- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects...
► Artikel lesen
31.03.25INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results105- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") system received FDA approval to assess kidney function -- Spectrum: Broadcasting...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1